I-CARE

[Julien Kirchgesner @J_Kirchgesner]

The 1st results of the @ICARE_ibd study were presented at #ECCOCongress2026. This is just the beginning, many more findings will emerge from this amazing cohort ! @PGetaid @PeyrinBiroulet #LaurentBeaugerie @baert_filip #JeanFrançoisRahier @ibdseb @FernandoMagro6

[I-CARE @ICARE_ibd]

We are now in sprint phase of @ICARE_ibd study .
This is a massive pan-European collaborative effort where ‘patient was the researcher ‘
Unique and transformational study which will inform practice

Look out for results

[I-CARE @ICARE_ibd]

ECCO 2023 conference in March : The Executive Committee and the entire #ICARE team are very proud to announce the freeze-in date of March 17, 2023. The #GETAID team would like to thank all the investigators at the centers for their hard work. We did it ! 💪

[Laurent Peyrin-Biroulet @PeyrinBiroulet]

The MICA study is published! The Getaid is in its best shape ever!
@PGetaid

https://t.co/vXKVMe2rMW

[Laurent Peyrin-Biroulet @PeyrinBiroulet]

15 years after the first CESAME paper, the first ICARE paper is available! A unique European prospective cohort of more than 10,000 IBD patients exposed to all approved biologics. We did it! Thanks to all investigators and the @PGetaid team. More to come😊https://t.co/6teipND97b